secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definitive Healthcare Corp. (DH)
CIK:        0001861795
Form:       8-K
Filed at:   2022-08-04T23:59:59+00:00
Accession:  0001193125-22-212516
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Definitive Healthcare Q2 revenue $54.5M (+37% YoY); net loss narrows; raises FY guidance
--------------------------------------------------------------------------------

- Revenue $54.5M (+37% YoY); net loss ($9.6M) improved from ($15.0M) in Q2 2021.
- Adjusted Net Income $8.9M (vs $2.0M); Adjusted EBITDA $16.3M (30% of revenue).
- Enterprise customers (ARR >$100k) reached 486; launched Passport Express and Monocl ExpertInsight 2.0.
- Q3 2022 revenue guidance $56-57M; FY 2022 revenue guidance $220.5-224.5M (34% YoY growth midpoint).
- Unlevered free cash flow $19.1M in Q2; trailing twelve months $63.4M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861795/000119312522212516/0001193125-22-212516-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861795/000119312522212516/d386811d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-212516

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer